LifeTime is a multi-disciplinary initiative linking leading European researchers and clinicians. They will revolutionize the way we understand and treat diseases.
The LifeTime Initiative, coordinated by Max Delbrück Center for Molecular Medicine in Berlin and Institut Curie in Paris, has developed a strategy to advance personalized treatment for five major disease classes: cancer, neurological-, infectious-, chronic inflammatory- and cardiovascular diseases.
By using breakthrough single-cell, and imaging technologies in combination with artificial intelligence and personalized disease models it will allow them to not only predict disease onset earlier but also to select the most effective therapies for individual patients.
The aim is a new age of personalized, cell-based interceptive medicine for Europe with the potential of improved health outcomes and more cost-effective treatment, resulting in profoundly changing a person’s healthcare experience.
Client: LifeTime Initiative
Copyright | GRUNERFILMS
